Clinical Research of Compound Zhebei Granules for Increasing the Therapeutic Effect of Chemotherapy in Refractory Acute Leukemia Patients

Outcome of Patients Treated for Relapsed

Outcome of Patients Treated for Relapsed or Refractory Acute Lymphoblastic Leukemia: A Therapeutic Advances in Childhood Leukemia Consortium Study

✍ Ko, R. H.; Ji, L.; Barnette, P.; Bostrom, B.; Hutchinson, R.; Raetz, E.; Seibel, 📂 Article 📅 2010 🏛 American Society of Clinical Oncology 🌐 English ⚖ 130 KB

Optimization of Chemotherapy for Younger

Optimization of Chemotherapy for Younger Patients With Acute Myeloid Leukemia: Results of the Medical Research Council AML15 Trial

✍ Burnett, A. K.; Russell, N. H.; Hills, R. K.; Hunter, A. E.; Kjeldsen, L.; Yin, 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 255 KB

Platelet transfusion in acute leukemia p

Platelet transfusion in acute leukemia patients with severe chemotherapy-induced thrombocytopenia: the possible importance of hemoglobin levels and red blood cell transfusions for evaluation of clinical effects of transfusion

✍ Torunn O. Apelseth; Tor Hervig; Øystein Bruserud 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Targeted therapy with the T-cell - Engag

Targeted therapy with the T-cell - Engaging antibody blinatumomab of chemotherapy-refractory minimal residual disease in B-lineage acute lymphoblastic leukemia patients results in high response rate and prolonged leukemia-free survival

✍ Topp, Max S. (author);Kufer, Peter (author);Gökbuget, Nicola (author);Goebeler, 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 135 KB

Targeted therapy with the T-cell - Engag

Targeted therapy with the T-cell - Engaging antibody blinatumomab of chemotherapy-refractory minimal residual disease in B-lineage acute lymphoblastic leukemia patients results in high response rate and prolonged leukemia-free survival

✍ Topp, Max S. (author);Kufer, Peter (author);Gökbuget, Nicola (author);Goebeler, 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 135 KB

PCN45 COST EFFECTIVENESS OF ADDING IMATI

PCN45 COST EFFECTIVENESS OF ADDING IMATINIB TO CHEMOTHERAPY IN ADULT PATIENTS WITH PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (PH+ALL):AN EXPLORATORY ANALYSIS FOR THE UK

✍ MF Botteman; KT Tran; JM Stephens 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB